We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
Cap. Flow
+$327M
Cap. Flow %
38.29%
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$13.6M
2
MRK icon
Merck
MRK
+$12.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.1M
4
DOCU
DocuSign
DOCU
+$10.9M
5
PODD icon
Insulet
PODD
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.68%
3 Healthcare 16.13%
4 Industrials 12.13%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIVN icon
51
Rivian
RIVN
$22B
$3.66M 0.43%
+150,768
New +$3.52M
NVDA icon
52
NVIDIA
NVDA
$4.86T
$3.66M 0.43%
84,140
+22,520
+37% +$1.01M
HOLX
53
DELISTED
Hologic
HOLX
$3.63M 0.42%
+52,310
New +$3.95M
BBY icon
54
Best Buy
BBY
$18.2B
$3.36M 0.39%
+48,296
New +$3.73M
ALGM icon
55
Allegro MicroSystems
ALGM
$7.73B
$3.22M 0.38%
100,921
+76,821
+319% +$3.12M
TSCO icon
56
Tractor Supply
TSCO
$16.1B
$3.2M 0.37%
78,870
+30,610
+63% +$1.33M
PXD
57
DELISTED
Pioneer Natural Resource Co.
PXD
$3.2M 0.37%
13,936
+11,378
+445% +$2.59M
CNX icon
58
CNX Resources
CNX
$5.3B
$3.15M 0.37%
139,443
+35,698
+34% +$740K
BMY icon
59
Bristol-Myers Squibb
BMY
$133B
$3.15M 0.37%
54,207
+29,263
+117% +$1.79M
NCLH icon
60
Norwegian Cruise Line
NCLH
$8.51B
$3.13M 0.37%
190,205
-115,127
-38% -$2.12M
BALL icon
61
Ball Corp
BALL
$17.3B
$3.1M 0.36%
+62,309
New +$3.4M
U icon
62
Unity
U
$13.8B
$3.08M 0.36%
98,048
+8,271
+9% +$318K
SHW icon
63
Sherwin-Williams
SHW
$82.7B
$3.05M 0.36%
11,957
+8,642
+261% +$2.31M
HSY icon
64
Hershey
HSY
$35.2B
$3.05M 0.36%
+15,228
New +$3.41M
V icon
65
Visa
V
$684B
$3.04M 0.36%
13,222
+4,210
+47% +$1.01M
UPST icon
66
Upstart Holdings
UPST
$2.63B
$3.02M 0.35%
105,683
+50,702
+92% +$2.04M
SPOT icon
67
Spotify
SPOT
$103B
$2.94M 0.34%
+19,041
New +$2.9M
LBTYK icon
68
Liberty Global Class C
LBTYK
$3.53B
$2.94M 0.34%
158,499
+1,233
+0.8% +$23.7K
CMG icon
69
Chipotle Mexican Grill
CMG
$47.2B
$2.87M 0.34%
78,250
-46,900
-37% -$1.83M
TMO icon
70
Thermo Fisher Scientific
TMO
$213B
$2.79M 0.33%
5,519
-2,794
-34% -$1.49M
FWRD icon
71
Forward Air
FWRD
$444M
$2.79M 0.33%
+40,572
New +$3.57M
ACHR icon
72
Archer Aviation
ACHR
$3.54B
$2.74M 0.32%
+541,400
New +$3.11M
ANET icon
73
Arista Networks
ANET
$227B
$2.71M 0.32%
59,036
-39,536
-40% -$1.76M
KNX icon
74
Knight Transportation
KNX
$11.3B
$2.7M 0.32%
53,799
+31,994
+147% +$1.77M
SPGI icon
75
S&P Global
SPGI
$121B
$2.65M 0.31%
7,252
+6,184
+579% +$2.43M

Similar funds

Seven Eight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.

  • Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
  • Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
  • Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
  • Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
  • Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
  • Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.